Why is Transgene Biotek falling/rising?

As of 08-Jul, Transgene Biotek Ltd's stock price is currently at 4.85, reflecting an increase of 0.03 or 0.62%. The stock has shown a strong performance recently, with a 5.66% increase over the past week and a notable 21.55% rise over the past month, significantly outperforming the Sensex, which has only increased by 0.02% in the same timeframe. However, despite this recent upward movement, the stock has experienced a decline of 28.99% year-to-date and 47.51% over the past year. Today's trading volume indicates a decrease in investor participation, with a delivery volume of 30.12k, down by 25.07% compared to the 5-day average. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, but remains below its 200-day moving average, suggesting mixed signals regarding its longer-term trend.
Broader Market Context: In the short term, Transgene Biotek's performance has significantly outpaced the benchmark Sensex, which has only gained 0.02% over the past week, while Transgene Biotek has gained 5.66%. This indicates a strong relative performance in the immediate term. However, the broader context reveals that the stock has struggled over the longer term, with substantial declines year-to-date and over the past year, contrasting sharply with the Sensex's 7.13% gain year-to-date. The liquidity of the stock remains adequate for trading, but the falling investor participation could be a concern for sustained upward momentum.